litlas
Log inCreate account

Hagop M. Kantarjian

Active 1983–2025

Also published as
Hagop M Kantarjian
1,143
Papers
219,315
Citations
232
h-index
1,113
i10-index

Citations

Citations per year for Hagop M. Kantarjian1948: 1 citations1975: 1 citations1979: 16 citations1984: 1 citations1985: 1 citations1986: 7 citations1987: 19 citations1988: 18 citations1989: 23 citations1990: 28 citations1991: 39 citations1992: 38 citations1993: 70 citations1994: 54 citations1995: 72 citations1996: 90 citations1997: 81 citations1998: 95 citations1999: 164 citations2000: 233 citations2001: 356 citations2002: 782 citations2003: 947 citations2004: 813 citations2005: 783 citations2006: 1,017 citations2007: 1,270 citations2008: 1,231 citations2009: 1,411 citations2010: 1,426 citations2011: 1,407 citations2012: 1,451 citations2013: 1,488 citations2014: 1,450 citations2015: 1,571 citations2016: 1,618 citations2017: 1,527 citations2018: 1,560 citations2019: 5,697 citations2020: 6,477 citations2021: 6,579 citations2022: 5,227 citations2023: 4,332 citations2024: 7,210 citations2025: 3,331 citations2026: 46 citations1949–1974: no citations, so these years are not shown1976–1978: no citations, so these years are not shown1980–1983: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 14,101 citing papers, 30.4% of this breakdownChina: 3,665 citing papers, 7.9% of this breakdownGermany: 3,216 citing papers, 6.9% of this breakdownUnited Kingdom: 2,798 citing papers, 6% of this breakdownItaly: 2,794 citing papers, 6% of this breakdownFrance: 2,283 citing papers, 4.9% of this breakdownCanada: 1,403 citing papers, 3% of this breakdownSpain: 1,351 citing papers, 2.9% of this breakdownAustralia: 1,210 citing papers, 2.6% of this breakdownNetherlands: 1,136 citing papers, 2.5% of this breakdownSwitzerland: 1,049 citing papers, 2.3% of this breakdownJapan: 1,047 citing papers, 2.3% of this breakdown
0%30.4%Other 22.3%

Institutions

Fields

  • Medicine68.8%
  • Biochemistry, Genetics and Molecular Biology22.7%
  • Immunology and Microbiology3.7%
  • Computer Science0.9%
  • Economics, Econometrics and Finance0.8%
  • Chemistry0.5%
  • Other2.6%

Topics

  • Acute Myeloid Leukemia Research9.4%
  • Chronic Myeloid Leukemia Treatments5.9%
  • Chronic Lymphocytic Leukemia Research4.5%
  • Acute Lymphoblastic Leukemia research3.7%
  • Myeloproliferative Neoplasms: Diagnosis and Treatment3.4%
  • CAR-T cell therapy research2.8%
  • Other70.3%

Coauthors

All papers

Open in search
  1. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms

    Authors: Joseph D. Khoury, Éric Solary, Oussama Abla, Yassmine Akkari, Rita Alaggio, Jane F. Apperley, Rafael Bejar, Emilio Berti, Lambert Busque, John K. C. Chan, Weina Chen, Xueyan Chen, Wee Joo Chng, John Choi, Isabel Colmenero, Sarah E. Coupland, Nicholas C.P. Cross, Daphne de Jong, M. Tarek Elghetany, Emiko Takahashi, Jean‐François Emile, Judith A. Ferry, Linda Fogelstrand, Michaëla Fontenay, Ulrich Germing, Sumeet Gujral, Torsten Haferlach, Claire Harrison, Jennelle C. Hodge, Shimin Hu, Joop H. Jansen, Rashmi Kanagal‐Shamanna, Hagop M. Kantarjian, Christian P. Kratz, Xiaoqiu Li, Megan S. Lim, Keith R. Loeb, Sanam Loghavi, Andrea N. Marcogliese, Soheil Meshinchi, Phillip Michaels, Kikkeri N. Naresh, Yasodha Natkunam, Reza Nejati, German Ott, Eric Padron, Keyur P. Patel, Nikhil Patkar, Jennifer Picarsic, Uwe Platzbecker, Irene Roberts, Anna Schuh, William A. Sewell, Reiner Siebert, Prashant Tembhare, Jeffrey Tyner, Srđan Verstovšek, Wei Wang, Brent L. Wood, Wenbin Xiao, Cecilia C.S. Yeung, Andreas Hochhaus - Leukemia 2022 cited by 3,904

  2. The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia

    Authors: Ghayas C. Issa, Ibrahim Aldoss, John F. DiPersio, Branko Cuglievan, Richard M. Stone, Martha Arellano, Michael J. Thirman, Manish R. Patel, David S. Dickens, Shalini Shenoy, Neerav Shukla, Hagop M. Kantarjian, Scott A. Armstrong, Florian Perner, Jennifer A. Perry, Galit Rosen, Rebecca G. Bagley, Michael L. Meyers, Peter Ordentlich, Yu Gu, Vinit Kumar, Steven G. Smith, Gerard M. McGeehan, Eytan M. Stein - Nature 2023 cited by 468

  3. Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia

    Authors: Courtney D. DiNardo, Keith W. Pratz, Vinod Pullarkat, Brian A. Jonas, Martha Arellano, Pamela S. Becker, Olga Frankfurt, Marina Konopleva, Andrew H. Wei, Hagop M. Kantarjian, Tu Xu, Wan‐Jen Hong, Brenda Chyla, Jalaja Potluri, Daniel A. Pollyea, Anthony Letai - Blood 2018 cited by 1,852

  4. Acute myeloid leukemia: current progress and future directions

    Authors: Hagop M. Kantarjian, Tapan M. Kadia, Courtney D. DiNardo, Naval Daver, Gautam Borthakur, Elias Jabbour, Guillermo Garcia‐Manero, Marina Konopleva, Farhad Ravandi - Blood Cancer Journal 2021 cited by 760

  5. Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials

    Authors: Timothy A. Yap, Naval Daver, Mikhila Mahendra, Jixiang Zhang, Carlos Kamiya-Matsuoka, Funda Meric‐Bernstam, Hagop M. Kantarjian, Farhad Ravandi, Meghan Collins, Maria Emilia Di Francesco, Ecaterina E. Dumbrava, Siqing Fu, Sisi Gao, Jason Gay, Sonal Gera, Jing Han, David S. Hong, Elias Jabbour, Zhenlin Ju, Daniel D. Karp, Alessia Lodi, Jennifer R. Molina, Natalia Baran, Aung Naing, Maro Ohanian, Shubham Pant, Naveen Pemmaraju, Prithviraj Bose, Sarina A. Piha‐Paul, Jordi Rodón, Carolina Salguero, Koji Sasaki, Anand Kumar Singh, Vivek Subbiah, Apostolia M. Tsimberidou, Quanyun A. Xu, Musa Yılmaz, Qi Zhang, Yuan Li, Christopher A. Bristow, Meenakshi B. Bhattacharjee, Stefano Tiziani, Timothy P. Heffernan, Christopher P. Vellano, Philip Jones, Cobi J. Heijnen, Annemieke Kavelaars, Joseph R. Marszalek, Marina Konopleva - Nature Medicine 2023 cited by 377

  6. European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia

    Authors: Andreas Hochhaus, Michele Baccarani, Richard T. Silver, CA Schiffer, Jane F. Apperley, Francisco Cervantes, R E Clark, J. E. Cortes, Michael W. Deininger, François Guilhot, Henrik Hjorth‐Hansen, Timothy P. Hughes, J. Janssen, Hagop M. Kantarjian, D. W. Kim, Richard A. Larson, J. H. Lipton, F.-X. Mahon, Jiří Mayer, Franck E. Nicolini, D Niederwieser, Fabrizio Pane, Jerald P. Radich, Delphine Réa, Johan Richter, G Rosti, Philipe Rousselot, Giuseppe Saglio, Susanne Saußele, Simona Soverini, J. L. Steegmann, Anna Turkina, Andrey Zaritskey, R. Hehlmann - Leukemia 2020 cited by 1,510

  7. Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML

    Authors: Courtney D. DiNardo, Ing Soo Tiong, Anna Quaglieri, Sarah MacRaild, Sanam Loghavi, Fiona C. Brown, Rachel Thijssen, Giovanna Pomilio, Adam Ivey, Jessica M. Salmon, Christina Glytsou, Shaun Fleming, Q. Zhang, Huaxian Ma, Keyur P. Patel, Steven M. Kornblau, Zhen Xu, Chong Chyn Chua, Xufeng Chen, Piers Blombery, Christoffer Flensburg, Nik Cummings, Iannis Aifantis, Hagop M. Kantarjian, David C.S. Huang, Andrew W. Roberts, Ian J. Majewski, Marina Konopleva, Andrew H. Wei - Blood 2020 cited by 649

  8. Durable Remissions with Ivosidenib in IDH1 -Mutated Relapsed or Refractory AML

    Authors: Courtney D. DiNardo, Eytan M. Stein, Stéphane de Botton, Gail J. Roboz, Jessica K. Altman, Alice S. Mims, Ronan Swords, Robert H. Collins, Gabriel N. Mannis, Daniel A. Pollyea, Will Donnellan, Amir T. Fathi, Arnaud Pigneux, Harry P. Erba, Gabrielle T. Prince, Anthony S. Stein, Geoffrey L. Uy, James M. Foran, Elie Traer, Robert K. Stuart, Martha Arellano, James L. Slack, Mikkael A. Sekeres, Christophe Willekens, Sung Choe, Hongfang Wang, Vickie Zhang, Katharine Yen, Stephanie M. Kapsalis, Hua Yang, David L. Dai, Bin Fan, Meredith A. Goldwasser, Hua Liu, Sam Agresta, Bin Wu, Eyal C. Attar, Martin S. Tallman, Richard M. Stone, Hagop M. Kantarjian - New England Journal of Medicine 2018 cited by 1,412

  9. Revised International Prognostic Scoring System for Myelodysplastic Syndromes

    Authors: Peter L. Greenberg, Heinz Tuechler, Julie Schanz, Guillermo Sanz, Guillermo Garcia‐Manero, Françesc Solé, John M. Bennett, David Bowen, Pierre Fenaux, François Dreyfus, Hagop M. Kantarjian, Andrea Kuendgen, Alessandro Levis, Luca Malcovati, Mario Cazzola, Jaroslav Čermák, Christa Fonatsch, Michelle M. Le Beau, Marilyn L. Slovak, Otto Krieger, Michael Luebbert, Jaroslaw P. Maciejewski, Silvia M. M. Magalhães, Yasushi Miyazaki, Michael Pfeilstöcker, Mikkael A. Sekeres, Wolfgang R. Sperr, Reinhard Stauder, Sudhir Tauro, Peter Valent, Teresa Vallespı́, Arjan A. van de Loosdrecht, Ulrich Germing, Detlef Haase - Blood 2012 cited by 3,140

  10. Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia

    Authors: Hagop M. Kantarjian, Daniel J. DeAngelo, Matthias Stelljes, Giovanni Martinelli, Michaela Liedtke, Wendy Stock, Nicola Gökbuget, Susan O’Brien, Kongming Wang, Tao Wang, M. Luisa Paccagnella, Barbara Sleight, Erik Vandendries, Anjali S. Advani - New England Journal of Medicine 2016 cited by 1,373

  11. A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis

    Authors: Srđan Verstovšek, Ruben A. Mesa, Jason Gotlib, Richard S. Levy, Vikas Gupta, John F. DiPersio, John Catalano, Michael W. Deininger, Carole B. Miller, Richard T. Silver, Moshe Talpaz, Elliott F. Winton, Jimmie H. Harvey, Murat O. Arcasoy, Elizabeth O. Hexner, Roger M. Lyons, Ronald Paquette, Azra Raza, Kris Vaddi, Susan Erickson‐Viitanen, Iphigenia L. Koumenis, William Sun, Victor Sandor, Hagop M. Kantarjian - New England Journal of Medicine 2012 cited by 2,050

  12. Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia

    Authors: Eytan M. Stein, Courtney D. DiNardo, Daniel A. Pollyea, Amir T. Fathi, Gail J. Roboz, Jessica K. Altman, Richard M. Stone, Daniel J. DeAngelo, Ross L. Levine, Ian W. Flinn, Hagop M. Kantarjian, Robert H. Collins, Manish R. Patel, Arthur E. Frankel, Anthony S. Stein, Mikkael A. Sekeres, Ronan Swords, Bruno C. Medeiros, Christophe Willekens, Paresh Vyas, Alessandra Tosolini, Qiang Xu, Robert Knight, Katharine Yen, Sam Agresta, Stéphane de Botton, Martin S. Tallman - Blood 2017 cited by 1,469

  13. Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies

    Authors: Reuben Benjamin, Charlotte Graham, Deborah Yallop, Agnieszka Jóźwik, Oana Mirci‐Danicar, Giovanna Lucchini, Danielle Pinner, Nitin Jain, Hagop M. Kantarjian, Nicolas Boissel, Marcela V. Maus, Matthew J. Frigault, André Baruchel, Mohamad Mohty, Athos Gianella-Borradori, Florence Binlich, Svetlana Balandraud, Fabien Vitry, E. W. Prosser Thomas, Anne Philippe, Sylvain Fouliard, Sandra Dupouy, Ibtissam Marchiq, Maria Almena-Carrasco, Nicolas Ferry, Sylvain Arnould, Cyril Konto, Paul Veys, Waseem Qasim, Reuben Benjamin, Charlotte Graham, Deborah Yallop, Agnieszka Jóźwik, Antonio Pagliuca, Ghulam Mufti, Piers Patten, Shireen Kassam, Stephen Devereux, Majid Kazmi, Kirsty Cuthill, Victoria Potter, Andrea Kühnl, Victoria Metaxa, Laarni Bonganay, Orla Stewart, Rose Ellard, Lorraine Catt, Jen Lewis, Farzin Farzaneh, Jackie Chappell, Alice Mason, Vicky Chu, Alan Dunlop, Adeel Saleem, Gary Cheung, Helena Munro, Elka Giemza, Waseem Qasim, Paul Veys, Oana Ciocârlie, Giovanna Lucchini, Danielle Pinner, Jan Chu, Persis Amrolia, Kanchan Rao, Robert Chiesa, Juliana Silva, Annette Hill, Maria Finch, Lindsey Young, Harvinder Hara, Sujith Samarasinghe, Anupama Rao, Ajay Vora, Anupama Rao, Christine Rivat, Clare Murphy, Gulrukh Ahsan, Rasha Said Shamsah, Jesmina James, Sarah Inglott, Gary Wright, Stuart Adams, Natalia Izotova, Nitin Jain, Marina Konopleva, William G. Wierda, Elias Jabbour, Hagop M. Kantarjian, Partow Kebrieai, Emily Jones, Kara McGee, Marcela V. Maus, Matthew J. Frigault, Jami Brown, Vesselina Toncheva, Keagan S. Casey, Hanno Hock, Meaghan A McKeown, Richard Mathews and 40 more - The Lancet 2020 cited by 360

  14. Efficacy and Biological Correlates of Response in a Phase II Study of Venetoclax Monotherapy in Patients with Acute Myelogenous Leukemia

    Authors: Marina Konopleva, Daniel A. Pollyea, Jalaja Potluri, Brenda Chyla, Leah J. Hogdal, Todd Busman, Evelyn McKeegan, Ahmed Hamed Salem, Ming Zhu, Justin L. Ricker, William Blum, Courtney D. DiNardo, Tapan M. Kadia, Martin Dunbar, Rachel Kirby, Nancy Falotico, Joel D. Leverson, Rod Humerickhouse, Mack Mabry, Richard M. Stone, Hagop M. Kantarjian, Anthony Letai - Cancer Discovery 2016 cited by 1,056

  15. The financial burden and distress of patients with cancer: Understanding and stepping‐up action on the financial toxicity of cancer treatment

    Authors: Pricivel M. Carrera, Hagop M. Kantarjian, Victoria Blinder - CA A Cancer Journal for Clinicians 2018 cited by 863

  16. Mitochondrial ClpP-Mediated Proteolysis Induces Selective Cancer Cell Lethality

    Authors: Jo Ishizawa, Sarah F. Zarabi, R. Eric Davis, Ondrej Halgas, Takenobu Nii, Yulia Jitkova, Ran Zhao, Jonathan St‐Germain, Lauren Heese, Grace Egan, Vivian Ruvolo, Samir H. Barghout, Yuki Nishida, Rose Hurren, Wencai Ma, Marcela Gronda, Todd Link, Keith S. Wong, Mark Mabanglo, Kensuke Kojima, Gautam Borthakur, Neil MacLean, Man Chun John, Andrew B. Leber, Mark D. Minden, Walid A. Houry, Hagop M. Kantarjian, Martin Stogniew, Brian Raught, E.F. Pai, Aaron D. Schimmer, Michael Andreeff - Cancer Cell 2019 cited by 354

  17. Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study

    Authors: Max S. Topp, Nicola Gökbuget, Anthony S. Stein, Gerhard Zugmaier, Susan O’Brien, Ralf C. Bargou, Hervé Dombret, Adele K. Fielding, Leonard T. Heffner, Richard A Larson, Svenja Neumann, Robin Foà, Mark R. Litzow, Josep‐María Ribera, Alessandro Rambaldi, Gary J. Schiller, Monika Brüggemann, Heinz A. Horst, Chris Holland, Catherine Jia, Tapan Maniar, Birgit Huber, Dirk Nagorsen, Stephen J. Forman, Hagop M. Kantarjian - The Lancet Oncology 2014 cited by 1,259

  18. Association of Measurable Residual Disease With Survival Outcomes in Patients With Acute Myeloid Leukemia

    Authors: Nicholas J. Short, Shouhao Zhou, Chenqi Fu, Donald A. Berry, Roland B. Walter, Sylvie Freeman, Christopher S. Hourigan, Xuelin Huang, Graciela Nogueras González, Hyunsoo Hwang, Xinyue Qi, Hagop M. Kantarjian, Farhad Ravandi - JAMA Oncology 2020 cited by 368

  19. Ponatinib and blinatumomab for Philadelphia chromosome-positive acute lymphoblastic leukaemia: a US, single-centre, single-arm, phase 2 trial

    Authors: Elias Jabbour, Nicholas J. Short, Nitin Jain, Xuelin Huang, Guillermo Montalban‐Bravo, Pinaki P. Banerjee, Katayoun Rezvani, Xianli Jiang, Kun Hee Kim, Rashmi Kanagal‐Shamanna, Joseph D. Khoury, Keyur P. Patel, Tapan M. Kadia, Naval Daver, Kelly S. Chien, Yesid Alvarado, Guillermo Garcia‐Manero, Ghayas C. Issa, Fadi Haddad, Monica Kwari, Jennifer Thankachan, Ricardo Delumpa, Walid Macaron, Rebecca Garris, Marina Konopleva, Farhad Ravandi, Hagop M. Kantarjian - The Lancet Haematology 2022 cited by 239

  20. Eprenetapopt (APR-246) and Azacitidine in TP53-Mutant Myelodysplastic Syndromes

    Authors: David A. Sallman, Amy E. DeZern, Guillermo Garcia‐Manero, David P. Steensma, Gail J. Roboz, Mikkael A. Sekeres, Thomas Cluzeau, Kendra Sweet, Amy F. McLemore, Kathy L. McGraw, John Puskas, Ling Zhang, Jiqiang Yao, Qianxing Mo, Lisa Nardelli, Najla H. Al Ali, Eric Padron, Greg Korbel, Eyal C. Attar, Hagop M. Kantarjian, Jeffrey E. Lancet, Pierre Fenaux, Alan F. List, Rami S. Komrokji - Journal of Clinical Oncology 2021 cited by 460

  21. Efficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II Study

    Authors: Naval Daver, Guillermo Garcia‐Manero, Sreyashi Basu, Prajwal Boddu, Mansour Alfayez, Jörge E. Cortes, Marina Konopleva, Farhad Ravandi‐Kashani, Elias Jabbour, Tapan M. Kadia, Graciela M. Nogueras‐González, Jing Ning, Naveen Pemmaraju, Courtney D. DiNardo, Michael Andreeff, Sherry Pierce, Tauna Gordon, Steven M. Kornblau, Wilmer Flores, Zainab Alhamal, Carlos E. Bueso‐Ramos, Jeffrey L. Jorgensen, Keyur P. Patel, Jorge Blando, James P. Allison, Padmanee Sharma, Hagop M. Kantarjian - Cancer Discovery 2018 cited by 571

  22. PPM1D Mutations Drive Clonal Hematopoiesis in Response to Cytotoxic Chemotherapy

    Authors: Joanne I. Hsu, Tajhal Dayaram, Ayala Tovy, Étienne De Braekeleer, Mira Jeong, Feng Wang, Jianhua Zhang, Timothy P. Heffernan, Sonal Gera, Jeffrey J. Kovacs, Joseph R. Marszalek, Christopher A. Bristow, Yuanqing Yan, Guillermo Garcia‐Manero, Hagop M. Kantarjian, George S. Vassiliou, P. Andrew Futreal, Lawrence A. Donehower, Koichi Takahashi, Margaret A. Goodell - Cell stem cell 2018 cited by 425

  23. A Phase 2 Trial of Ponatinib in Philadelphia Chromosome–Positive Leukemias

    Authors: Jörge E. Cortes, D. W. Kim, Javier Pinilla‐Ibarz, Philipp le Coutre, Ronald Paquette, Charles Chuah, Franck E. Nicolini, Jane F. Apperley, H. Jean Khoury, Moshe Talpaz, John F. DiPersio, Daniel J. DeAngelo, Elisabetta Abruzzese, Delphine Réa, Michele Baccarani, Martin C. Müller, Carlo Gambacorti‐Passerini, Siu‐Fun Wong, Stephanie Lustgarten, Victor M. Rivera, Tim Clackson, Christopher D. Turner, Frank G. Haluska, François Guilhot, Michael W. Deininger, Andreas Hochhaus, Timothy P. Hughes, John M. Goldman, Neil P. Shah, Hagop M. Kantarjian - New England Journal of Medicine 2013 cited by 1,124

  24. Selective BCL-2 Inhibition by ABT-199 Causes On-Target Cell Death in Acute Myeloid Leukemia

    Authors: Rongqing Pan, Leah J. Hogdal, Juliana M. Benito, Donna Bucci, Lina Han, Gautam Borthakur, Jörge E. Cortes, Daniel J. DeAngelo, LaKeisha Debose, Hong Mu, Hartmut Döhner, Verena I. Gaidzik, Ilene Galinsky, Leonard S. Golfman, Torsten Haferlach, Karine G. Harutyunyan, Jianhua Hu, Joel D. Leverson, Guido Marcucci, Markus Müschen, Rachel Newman, Eugene Park, Peter P. Ruvolo, Vivian Ruvolo, Jeremy Ryan, Sonja Schindela, Patrick A. Zweidler‐McKay, Richard M. Stone, Hagop M. Kantarjian, Michael Andreeff, Marina Konopleva, Anthony Letai - Cancer Discovery 2013 cited by 735